+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Asthma Spacers Market (2021-2026) by Product Type, Distribution Channel, End-Users, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5503450
  • Report
  • September 2021
  • Region: Global
  • 187 Pages
  • Infogence Global Research

FEATURED COMPANIES

  • Allergan plc
  • AstraZeneca Plc
  • Blue Echo care LIc
  • GlaxoSmithKline plc
  • KOO Medical Equipment
  • OptimHal-ProtecSom SAS
The Global Asthma Spacers Market is estimated to be USD 1.6 Bn in 2021 and is expected to reach USD 2.12 Bn by 2026, growing at a CAGR of 5.8%.



Market Dynamics

The major factor driving the growth of the asthma spacers market is the increasing prevalence of asthma due to unhealthy lifestyles, rising geriatric population, growing number of smokers, rising obesity, and increasing pollution. Furthermore, increasing awareness programs by public and private organizations are expected to escalate the market growth. However, stringent government regulations for the production and sale of asthma spacers may hamper the market growth.

Rising research and development activities to launch innovative products, and reduced manufacturing cost is anticipated to offer remunerative growth opportunities for the player operating in the asthma spacers market.

Market Segmentation

The Global Asthma Spacers Market is segmented further based on Product Type, Distribution Channel, End-Users, and Geography.

By Product Type, the market is classified into Aerochamber, Inspirease, Optichamber, Volumatic, and Others. Amongst all, the Volumatic segment is estimated to hold the highest market share during the forecast period.

By Distribution Channel, the market is classified as Online Pharmacy, Hospital Pharmacy, and Retail Pharmacy. Amongst all, the Hospital Pharmacy segment is estimated to hold the highest market share during the forecast period.

By End-User, the market is classified as Homecare, Clinic & Hospitals, and Others. Amongst all, the Homecare segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. AstraZeneca has concluded the acquisition of a US-based biopharmaceutical company called Alexion Pharmaceuticals for a total consideration amount of $39bn or $175 per share. - 22nd July 2021
2. Eakin acquired Armstrong Medical in the significant expansion of Co Down healthcare group - 19th December 2019

Company Profiles

Some of the companies covered in this report are Armstrong Medical Ltd., Blue Echo care Llc, Clement Clarke International Ltd, Pari GmbH, DTF Medical, KOO Medical Equipment, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Asthma Spacers Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Asthma Spacers Market

What is the estimated value of the Global Asthma Spacers Market?

The Global Asthma Spacers Market was estimated to be valued at $1600.0 Million in 2021.

What is the growth rate of the Global Asthma Spacers Market?

The growth rate of the Global Asthma Spacers Market is 5.8%, with an estimated value of $2120.0 Million by 2026.

What is the forecasted size of the Global Asthma Spacers Market?

The Global Asthma Spacers Market is estimated to be worth $2120.0 Million by 2026.

Who are the key companies in the Global Asthma Spacers Market?

Key companies in the Global Asthma Spacers Market include Air Liquid Medical Systems Pvt Ltd, Armstrong Medical Ltd, AstraZeneca Plc, Blue Echo care LIc, Bird Healthcare Pty. Ltd., Cipla Limited, Clement Clarke International Ltd, La Diffusion Technique Française (DTF Medical) and GlaxoSmithKline plc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan plc
  • AstraZeneca Plc
  • Blue Echo care LIc
  • GlaxoSmithKline plc
  • KOO Medical Equipment
  • OptimHal-ProtecSom SAS

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Prevalence of Respiratory Diseases
4.1.2 Public and Private Organization Initiatives for Asthma Awareness
4.1.3 Rising Elderly Population and Healthcare Expenditure
4.1.4 Increasing Technological Advancements
4.2 Restraints
4.2.1 Lack of Awareness
4.2.2 Expensive Products
4.2.3 High-Quality Standards from Government
4.3 Opportunities
4.3.1 Rising Research and Development to Launch Innovative Products
4.3.2 Reduced Manufacturing Cost in Developing Countries
4.4 Challenges
4.4.1 Availability of Alternative Treatments for Asthma such as Bronchial Thermoplasty
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Asthma Spacers Market, By Product Type
6.1 Introduction
6.2 Aerochamber
6.3 Inspirease
6.4 Optichamber
6.5 Volumatic
6.6 Others
7 Global Asthma Spacers Market, By Distribution Channel
7.1 Introduction
7.2 Online Pharmacy
7.3 Hospital Pharmacy
7.4 Retail Pharmacy
8 Global Asthma Spacers Market, By End-User
8.1 Introduction
8.2 Homecare
8.3 Clinics and Hospital
8.4 Others
9 Global Asthma Spacers Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.3.3 Chile
9.3.4 Colombia
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Spain
9.4.6 Netherlands
9.4.7 Sweden
9.4.8 Russia
9.4.9 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Indonesia
9.5.5 Malaysia
9.5.6 South Korea
9.5.7 Australia
9.5.8 Sri Lanka
9.5.9 Thailand
9.5.10 Rest of APAC
9.6 Middle-East and Africa
9.6.1 Qatar
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 United Arab Emirates
10 Competitive Landscape
10.1 IGR Competitive Quadrant
10.2 Market Share Analysis
10.3 Strategic Initiatives
10.3.1 M&A and Investments
10.3.2 Partnerships and Collaborations
10.3.3 Product Developments and Improvements
11 Company Profiles
11.1 Air Liquid Medical Systems Pvt Ltd
11.2 Armstrong Medical Ltd
11.3 AstraZeneca Plc
11.4 Blue Echo care LIc
11.5 Bird Healthcare Pty. Ltd.
11.6 Cipla Limited
11.7 Clement Clarke International Ltd
11.8 La Diffusion Technique Française (DTF Medical)
11.9 Taian Dalu Medical Instrument Co., Ltd.
11.10 GlaxoSmithKline plc
11.11 KOO Medical Equipment
11.12 Lupin Pharmaceuticals, Inc.
11.13 Medical Developments International
11.14 Merck & Co. inc.
11.15 OptimHal-ProtecSom SAS
11.16 Pari GmbH
11.17 Respiratory Delivery Systems, Inc.
11.18 Salter Labs (SL)
11.19 Truedell Medical International
11.20 Teleflex Incorporated
11.21 Koninklijke Philips N.V
11.22 Visiomed Group Ltd.
11.23 Allergan plc
11.24 Intas Pharmaceuticals, Ltd.
12 Appendix
12.1 Questionnaire
Note: Product cover images may vary from those shown
  • Air Liquid Medical Systems Pvt Ltd
  • Armstrong Medical Ltd
  • AstraZeneca Plc
  • Blue Echo care LIc
  • Bird Healthcare Pty. Ltd.
  • Cipla Limited
  • Clement Clarke International Ltd
  • La Diffusion Technique Française (DTF Medical)
  • Taian Dalu Medical Instrument Co., Ltd.
  • GlaxoSmithKline plc
  • KOO Medical Equipment
  • Lupin Pharmaceuticals, Inc.
  • Medical Developments International
  • Merck & Co. inc.
  • OptimHal-ProtecSom SAS
  • Pari GmbH
  • Respiratory Delivery Systems, Inc.
  • Salter Labs (SL)
  • Truedell Medical International
  • Teleflex Incorporated
  • Koninklijke Philips N.V
  • Visiomed Group Ltd.
  • Allergan plc
  • Intas Pharmaceuticals, Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...